Cerus (CERS) Net Equity Issued and Repurchased (2010 - 2026)
Cerus' (CERS) quarterly Net Equity Issued and Repurchased came in at -$55000.0 in Q2 2026, down 77.42% year-over-year from -$243571.4 in Q2 2025, and down 205.77% quarter-over-quarter from $52000.0 in Q3 2025.
Powered by 
Analysis
Cerus (CERS) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Cerus has disclosed Net Equity Issued and Repurchased across 17 years of filings, most recently posting -$55000.0 for Q2 2026.
- In Q2 2026, Net Equity Issued and Repurchased fell 77.42% year-over-year to -$55000.0; the TTM figure through Jun 2026 stood at -$3000.0 (up 98.11% YoY), while the FY2025 annual figure was -$35000.0, up 74.45% from the prior year.
- Net Equity Issued and Repurchased came in at -$55000.0 for Q2 2026 at Cerus, down from $52000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $52000.0 in Q3 2022 to a low of -$72000.0 in Q1 2023.
- Average Net Equity Issued and Repurchased over 5 years is -$34333.3, with a median of -$48500.0 recorded in 2024.
- Year-over-year, Net Equity Issued and Repurchased sank 102.0% in 2022 and surged 223.81% in 2025.
- Over 5 years, Net Equity Issued and Repurchased stood at -$62000.0 in 2022, then jumped by 38.71% to -$38000.0 in 2023, then advanced by 21.05% to -$30000.0 in 2024, then soared by 273.33% to $52000.0 in 2025, then plunged by 205.77% to -$55000.0 in 2026.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were -$55000.0 in Q2 2026, $52000.0 in Q3 2025, and -$31000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn | -55,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | -31,000.00 |
| Mar 31, 2025 | -56,000.00 |
| Dec 31, 2024 | -30,000.00 |
| Sep 30, 2024 | -42,000.00 |
| Jun 30, 2024 | -65,000.00 |
| Dec 31, 2023 | -38,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Mar 31, 2023 | -72,000.00 |
| Dec 31, 2022 | -62,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Dec 31, 2021 | 3.10 Mn |
| Sep 30, 2021 | -67,000.00 |
| Dec 31, 2020 | -13,000.00 |
| Sep 30, 2020 | -48,000.00 |
| Jun 30, 2020 | 8.90 Mn |
| Mar 31, 2020 | 67.70 Mn |
| Dec 31, 2019 | 9.13 Mn |
| Sep 30, 2019 | 11.02 Mn |